NYSE:CHEHealthcare
Is Chemed (CHE) Fully Valued On Barington Capital's Push For Change?
Barington Capital has escalated its campaign at Chemed (CHE), pressing the board to launch a strategic review, cut executive perks, and refresh governance. These moves put fresh attention on how the company allocates capital.
See our latest analysis for Chemed.
Chemed’s share price has moved to US$511.13, with a 1 month share price return of 10.33% and a 3 month share price return of 21.38%. The 1 year total shareholder return of 10.26% contrasts with a slightly negative 3 year total...